Page 172 - CW E-Magazine (21-1-2025)

News from Abroad

You Name The Challenge,
PHARMA ALLIANCE
Evonik bolsters nucleic acids offering with ST We Deliver

Pharm partnership The Solution.

Evonik is partnering with ST companies using mRNA technology can
Pharm, a CDMO based in South Korea easily access this technology, and Smart-
that manufactures active ingredients for Cap has already demonstrated its feasi-
gene therapy, to expand its RNA and bility in human clinical trials.
nucleic acid therapeutic services.
“Partnering with Evonik, which has
Through the partnership, Evonik drug product manufacturing facilities Antifoams and
can provide customised nucleic acids in North America, allows us to expand Defoamer
from ST Pharm alongside its portfolio streamline the process and offer system into the global mRNA market while
of lipid and lipid nanoparticle (LNP) solutions. We look forward to support- strengthening existing customer rela- • Silicone based Defoamers
drug product development services. ing our customers in developing the tionships,” said Mr. Kris Choi, Head • Non silicone Defoamers
This streamlined approach means that nucleic-acid therapeutics of the future,” of Marketing & BD at ST Pharm. “Our • Mineral Oil based Defoamers
pharmaceutical companies can reduce said Mr. Yann d’Hervé, Head of the mRNA development expertise, includ- • Speciality surfactant based Defoamers
complexity and increase speed-to-mar- Health Care business line. ing SmartCap technology, aligns seam- • Polymeric Defoamers
ket for nucleic acid therapeutics. lessly with Evonik’s LNP and Fill & • Gemini surfactant based Defoamers
ST Pharm is a top-tier provider of Finish capabilities.” • Water based Defoamers
As part of the company’s Nutrition & active pharmaceutical ingredients (APIs)
Care division, Evonik’s Health Care including siRNAs, mRNA-LNPs and Evonik supplies pharmaceutical
business is making signifi cant invest- small molecule manufacturing. The companies with lipids and services
ments and partnering with leaders in company has also broadened its exper- for the development and GMP-manu- Other Speciality Chemicals All Grades of Simethicone
life sciences and industry to grow its tise in oligonucleotides and enzymatic facturing of LNPs and liposomes for
portfolio of system solutions for nucleic biotransformation including compre- gene delivery. Lipids, essential building • Wetting Agents and Simethicone
acid medicines. System solutions are hensive mRNA CDMO services. blocks of cells, enable the effective • Acrylic and HASE Thickeners Emulsion (USP/IP)
tailored offerings that integrate pro- encapsulation and delivery of mRNA and • In Can Preservatives
ducts, technologies and services, ena- A notable highlight of ST Pharm’s other nucleic acid drugs. Nucleic acid • Dry film Preservatives Industries We Serve
bling Evonik to support customers from portfolio is its proprietary 5’-capping therapeutics are rapidly growing within • Emulsifiers (Low foaming) • Paints & Coating • Pulp & Paper
ideation to the fi nished product. technology, SmartCap. This technology the parenteral drugs market. The LNP • 2- Phenoxy Ethanol • Inks & Resins • Waste Water Treatment
features 30 capping analogs and capping market alone is estimated to be over • Pigments • Cement asbestos sheet
“Speed is critical in drug deve- library screening services to optimise $600-mn (up to $1-bn) with continued • Flocculants (Cationic and Anionic)
lopment, and this partnership helps to mRNA development. Drug development growth projected over the next decade. • Silicone Oils • Dyes Intermediates • Sugar & Distilleries
• Silicone Emulsions • Textiles • Bulk Drugs & Fermentation
Songwon gets new partner to distribute PVC stabilisers • Silicone Softeners • Potato Processing • Latex Gloves
• Plastics
• Adhesives
in Middle East • Metal working Fluids • Tyres / Car polish

South Korean speciality chemicals etc. “With its team of experts and deca- East PVC market is forecasted to see
fi rm, Songwon Industrial Co. Ltd., has des of experience in the Middle East rapid growth in the coming years, driven
announced that its PVC sub business and North Africa region, Altek has an by a surge in building projects, rapid
unit has entered into a new distribution extensive network across GCC coun- urbanisation and the increasing demand
partnership with Altek International tries and is well-positioned to distribute for PVC across industries like con-
FZE in the Middle East. Songwon’s PVC stabilisers,” Songwon struction, packaging and electrical. As Scan this code
said. a result, the region is rapidly emerging For Sales and Distribution inquiries- please write to info@rossari.com to know more about us
Dubai-based Altek specialises in as a key player in the global PVC mar- ROSSARI BIOTECH LIMITED,
(An ISO 9001:2015 & 14001:2015 Certified Company)
the supply of raw materials for indus- Commenting on the partnership, ket with customers seeking high-qua- 201 A - B, 2nd Floor, Akruti Corporate Park, L.B.S Marg, Next to GE Gardens, Kanjurmarg (W), Mumbai - 400078, India.
tries such as rubber, petrochemicals, Mr. Bouzid Hamcherif, Leader of PVC lity PVC stabilisers from trusted +91 22 6123 3800 / 9033455553 / 9512054949 www.rossari.com
oil & gas, plastics, coatings, abrasives, sub business unit, said, “The Middle suppliers”.

172 Chemical Weekly January 21, 2025

Contents Index to Advertisers Index to Products Advertised